HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence of posterior capsule opacification in eyes with exfoliation syndrome and heparin-surface-modified intraocular lenses.

Abstract
Conventional poly(methyl methacrylate) (PMMA) intraocular lenses (IOLs) and heparin-surface-modified (HSM) IOLs were implanted after extracapsular cataract extraction in 40 human eyes with exfoliation syndrome. The study was double-masked and randomized. Two years after surgery 17 cases with HSM IOLs and 15 with PMMA IOLs were examined. We observed that pigment and cell deposits were more frequent on the PMMA than on the HSM IOLs. The incidence of posterior synechia formation was similar in both groups. However, the incidence of neodymium:YAG laser posterior capsulotomy and posterior capsule opacification was more frequent in the PMMA IOL group. Visual acuity did not differ between the two groups before or two years after surgery. The results suggest that in eyes with exfoliation syndrome, implanting an HSM IOL reduces the incidence of posterior capsule opacification often associated with extracapsular cataract extraction.
AuthorsC Zetterström
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 19 Issue 3 Pg. 344-7 (May 1993) ISSN: 0886-3350 [Print] United States
PMID8501628 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Methylmethacrylates
  • Methylmethacrylate
  • Heparin
Topics
  • Aged
  • Aged, 80 and over
  • Anterior Eye Segment
  • Cataract (etiology, pathology)
  • Cataract Extraction
  • Double-Blind Method
  • Eye Diseases (surgery)
  • Heparin
  • Humans
  • Incidence
  • Lens Capsule, Crystalline (pathology)
  • Lenses, Intraocular (adverse effects)
  • Methylmethacrylate
  • Methylmethacrylates
  • Middle Aged
  • Postoperative Complications
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: